Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Comprehensive Research-oriented Ward · Peking University Cancer Hospital · Beijing

Dr. Xie Yuntao解云涛

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

XY

Professional overview

Chief Physician and Professor at Peking University Cancer Hospital, specializing in surgical and comprehensive management of breast cancer.

SpecialtyComprehensive Research-oriented Ward
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentComprehensive Research-oriented Ward
HospitalPeking University Cancer Hospital
CityBeijing
Hospital roleDirector, Breast Center Laboratory, Peking University Cancer Hospital; Director, Center for Hereditary Tumors; Deputy Director, Department of Surgery Teaching Office

Areas of focus

Breast cancer surgeryPerforms various types of surgical treatment for breast cancer.
Breast-conserving surgeryPerforms breast-conserving surgery for Stage I–II breast cancer patients.
Sentinel lymph node biopsyPerforms sentinel lymph node biopsy for Stage I–II breast cancer patients.
Systemic therapy for breast cancerCombines preoperative and postoperative systemic comprehensive treatment with surgical management of breast cancer.
Hereditary breast cancerProvides diagnosis and treatment for familial hereditary breast cancer.

Background

  • 1986Graduated with a Bachelor's degree from the Medical School of Wuhan University.
  • 1992Received a Master's degree in Surgery from the Medical School of Wuhan University; began working in the Department of Oncological Surgery, Zhongnan Hospital of Wuhan University.
  • 2002Received a Ph.D. in Oncology/Cellular and Molecular Tumor Pathology from Karolinska Institutet, Sweden.
  • 2003Joined the Breast Center, Peking University Cancer Hospital.

Experience & recognition

  • Selected as one of the 'Beijing Hundred Leading Talents in Science and Technology' in 2015.
  • Led team to complete BRCA1/2 germline testing in 5,931 breast cancer cases.
  • Identified China-specific BRCA1/2 mutation spectrum in breast cancer patients.
  • First kin-cohort study in China estimating cumulative breast cancer risk to age 70 for BRCA1 (37.9%) and BRCA2 (36.5%) healthy carriers.
  • Discovered RECQL as a novel breast cancer susceptibility gene using whole-exome sequencing.

Professional roles

  • Member, Breast Cancer Committee, China Anti-Cancer Association (CACA)
  • Director, Breast Center Laboratory, Peking University Cancer Hospital
  • Director, Center for Hereditary Tumors, Peking University Cancer Hospital
  • Deputy Director, Department of Surgery Teaching Office, Peking University Cancer Hospital

Frequently asked questions

What does Dr. Xie Yuntao specialize in?

Specializes in surgical treatment of breast cancer—including breast-conserving surgery and sentinel lymph node biopsy for Stage I–II patients—as well as preoperative and postoperative systemic comprehensive treatment and diagnosis/treatment of hereditary breast cancer.

Which hospital and department is Dr. Xie Yuntao in?

Works in the Comprehensive Research-oriented Ward at Peking University Cancer Hospital.

Sources

Dr. Xie Yuntao has not reviewed this page.